Skip to Main Content

ethics

Here’s the latest on ethics in medicine, science and technology. Topics include gene editing, artificial intelligence, the use of big data in health care, potential conflicts of interest and an array of moral quandaries.

Latest

Exclusive Megan Molteni

STAT Plus: A pariah in science, the ‘CRISPR babies’ researcher gains support from a U.S. cryptocurrency entrepreneur

Health Meghana Keshavan

STAT Plus: Three MDMA therapy papers retracted over ethics violations

A STAT Investigation Katherine Eban

Mount Sinai mounted aggressive campaign to stifle debate over revelations about its controversial brain research

Pharmalot Ed Silverman

STAT Plus: NIH loses suit over censoring social media comments made by animal rights advocates

First Opinion Spencer Phillips Hey and Michael S. Wilkes

IRBs fail to assess trials’ scientific merit, putting participants at risk

Special Report Ashley Smart — Undark

5 takeaways from the Human Genome Project investigation

Special Report Ashley Smart — Undark

The untold story of the Human Genome Project: How one man’s DNA became a pillar of genetics

Biotech Timmy Broderick

STAT Plus: Gene therapies for deafness dredge up an old question: Do deaf people want a ‘cure’?

All Coverage

In the Lab Mark Arsenault — Boston Globe

STAT Plus: Former MIT biologist David Sabatini, forced out after sexual harassment accusations, to lead new Boston team

First Opinion Casimir Klim

Lessons to psychiatrists-in-training from the CIA’s mind-control projects

advertisement

Health tech Timmy Broderick

STAT Plus: The next frontier in data privacy? Your brain

Health Annalisa Merelli

New HHS guidance requires consent for pelvic, breast, and other sensitive examinations

In the Lab Nicholas St. Fleur

Q&A: Stem cell biologist predicts human embryo models could pave the way to organ transplants

First Opinion Joel B. Zivot

A new Louisiana capital-punishment bill would fundamentally alter physician licensing

First Opinion Christina S. Beck

How much personal health information does King Charles owe the public?

Health Care Associated Press

Studies cited in abortion pill case are retracted due to flaws and conflicts of interest

First Opinion Robert Klitzman

What the pope is missing about commercial surrogacy

First Opinion Joel B. Zivot

I’m an anesthesiologist. Kenneth Smith’s execution by nitrogen gas was far from ‘textbook’

In the Lab Mark Arsenault — Boston Globe

STAT Plus: Former MIT biologist, who lost positions after engaging in a prohibited sexual relationship, accepts new science position in Prague

First Opinion Michael H. Bernstein and Grayson L. Baird

Phenylephrine is no better than a placebo. What if that’s still better than nothing?

Health tech Lizzy Lawrence

STAT Plus: Artificial wombs, after years in development, reach FDA review for human trials

First Opinion Gregory E. Kaebnick

The morally ground-shifting legacy of Ian Wilmut and Dolly the sheep

Health Theresa Gaffney

Randomized controlled trials are the ‘gold standard’ of research — but a difficult fit for trans care

In the Lab Megan Molteni

New definition of a human embryo proposed amid rapid scientific advances

In the Lab Megan Molteni

STAT Plus: Global controversy heats up the race to build human embryo models from stem cells

First Opinion Arthur L. Caplan

STAT Plus: How I helped Pfizer think through the ethics of Viagra 25 years ago

First Opinion Eric D. Perakslis, Katie D. McMillan, and Jessilyn Dunn

Proposed rules to protect health data in an era of abortion bans fall short

First Opinion Noura Abul-Husn

Why the rise of DNA testing is creating challenges — and an opportunity

First Opinion Martha Gershun

Living kidney donors rely on a promise to protect our future health. We’re scared it will go away